Ark-ADMET: endpoint-specific selection of molecular representations and hyperparameters for gradient-boosted ADMET models under the Therapeutics Data Commons benchmark protocol
The Ark-ADMET study demonstrates that tailoring molecular representations and CatBoost hyperparameters to individual ADMET endpoints, rather than applying a uniform architecture across all tasks, yields competitive or superior performance on the Therapeutics Data Commons benchmark without requiring new model architectures.